This inventor holds 2 USPTO granted patents. Top assignees: The Green Cross Corporation, Morinaga Milk Industry Co., Ltd.. Active years: 1984-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1984-1991
Title: Kazuo Morimoto: Innovator in Biochemical Patents
Introduction
Kazuo Morimoto is a notable inventor based in Fukuchiyama, Japan. He has made significant contributions to the field of biochemistry, particularly through his innovative patents. With a total of 2 patents, Morimoto has focused on advancements that have the potential to impact medical and therapeutic applications.
Latest Patents
Morimoto's latest patents include a method for stabilizing plasminogen activator precursor and a method for preparing human urine-origin colony-stimulating factor. The first patent describes a plasminogen activator precursor that can be stabilized by adding various compounds, such as poly-C1-C5-alkylene glycols and polyethylene-polyoxypropylene copolymers, to its solution. The second patent outlines a process for separating human urine-origin colony-stimulating factor and kallikrein from an aqueous solution, utilizing stabilizers and high-performance gel filtration techniques.
Career Highlights
Throughout his career, Kazuo Morimoto has worked with reputable companies, including the Green Cross Corporation and Morinaga Milk Industry Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in the field of biochemistry.
Collaborations
Morimoto has collaborated with notable colleagues such as Shusaku Narita and Satoshi Funakoshi. These partnerships have likely fostered an environment of creativity and innovation, leading to the development of impactful patents.
Conclusion
Kazuo Morimoto's contributions to biochemistry through his patents demonstrate his commitment to innovation and advancement in the field. His work continues to influence medical research and applications, showcasing the importance of inventors in driving progress.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile